메뉴 건너뛰기




Volumn 59, Issue 7, 2010, Pages 503-510

Associations between plasma insulin-like growth factor-I and the markers of inflammation interleukin 6, C-reactive protein and YKL-40 in an elderly background population

Author keywords

C reactive protein; Inflammation; Insulin like growth factor I; Interleukin 6; YKL 40

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6; SOMATOMEDIN C; UNCLASSIFIED DRUG; YKL 40; ADIPOCYTOKINE; CHI3L1 PROTEIN, HUMAN; GLYCOPROTEIN; LECTIN;

EID: 77955710340     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-009-0154-z     Document Type: Article
Times cited : (11)

References (41)
  • 1
    • 0043198265 scopus 로고    scopus 로고
    • Serum levels of insulin-like growth factor I and its binding proteins in health and disease
    • Juul A. Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm IGF Res. 2003;13(4):113-70.
    • (2003) Growth Horm IGF Res. , vol.13 , Issue.4 , pp. 113-70
    • Juul, A.1
  • 2
    • 57149104111 scopus 로고    scopus 로고
    • Immune dysregulation and chronic stress among older adults: A review
    • Gouin JP, Hantsoo L, Kiecolt-Glaser JK. Immune dysregulation and chronic stress among older adults: a review. Neuroimmunomodulation. 2008;15(4-6):251-9.
    • (2008) Neuroimmunomodulation. , vol.15 , Issue.4-6 , pp. 251-9
    • Gouin, J.P.1    Hantsoo, L.2    Kiecolt-Glaser, J.K.3
  • 3
    • 0034051068 scopus 로고    scopus 로고
    • Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty
    • Ershler WB, Keller ET. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Ann Rev Med. 2000;51:245-70.
    • (2000) Ann Rev Med. , vol.51 , pp. 245-70
    • Ershler, W.B.1    Keller, E.T.2
  • 5
    • 0036280436 scopus 로고    scopus 로고
    • The role of endotoxin, TNF-alpha, and IL-6 in inducing the state of growth hormone insensitivity
    • Wang P, Li N, Li JS, Li WQ. The role of endotoxin, TNF-alpha, and IL-6 in inducing the state of growth hormone insensitivity. World J Gastroenterol. 2002;8(3):531-6.
    • (2002) World J Gastroenterol. , vol.8 , Issue.3 , pp. 531-6
    • Wang, P.1    Li, N.2    Li, J.S.3    Li, W.Q.4
  • 6
    • 14644404961 scopus 로고    scopus 로고
    • Cytokine inhibition of JAKSTAT signaling: A new mechanism of growth hormone resistance
    • Lang CH, Hong-Brown L, Frost RA. Cytokine inhibition of JAKSTAT signaling: a new mechanism of growth hormone resistance. Pediatr Nephrol. 2005;20(3):306-12.
    • (2005) Pediatr Nephrol. , vol.20 , Issue.3 , pp. 306-12
    • Lang, C.H.1    Hong-Brown, L.2    Frost, R.A.3
  • 10
    • 0038369150 scopus 로고    scopus 로고
    • Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women
    • CappolaAR, XueQL, Ferrucci L,GuralnikJM,Volpato S, Fried LP. Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women. J Clin Endocrinol Metab. 2003;88(5):2019-25.
    • (2003) J Clin Endocrinol Metab. , vol.88 , Issue.5 , pp. 2019-25
    • Cappola, A.R.1    Xue, Q.L.2    Ferrucci, L.3    Guralnik, J.M.4    Volpato, S.5    Fried, L.P.6
  • 11
    • 2642541669 scopus 로고    scopus 로고
    • Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty
    • Leng SX, Cappola AR, Andersen RE, Blackman MR, Koenig K, Blair M, et al. Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty. Aging Clin Exp Res. 2004;16(2):153-7.
    • (2004) Aging Clin Exp Res. , vol.16 , Issue.2 , pp. 153-7
    • Leng, S.X.1    Cappola, A.R.2    Andersen, R.E.3    Blackman, M.R.4    Koenig, K.5    Blair, M.6
  • 12
    • 33646842919 scopus 로고    scopus 로고
    • Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer
    • Johansen JS. Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. Dan Med Bull. 2006;53(2):172-209.
    • (2006) Dan Med Bull. , vol.53 , Issue.2 , pp. 172-209
    • Johansen, J.S.1
  • 13
    • 0344974146 scopus 로고    scopus 로고
    • The Frederiksberg Heart Failure Study: Rationale, design and methodology, with special emphasis on the sampling procedure for the study population and its comparison to the background population
    • Raymond I, Pedersen F, Busch-Sorensen M, Green A, Hildebrandt P. The Frederiksberg Heart Failure Study: Rationale, design and methodology, with special emphasis on the sampling procedure for the study population and its comparison to the background population. Heart Drug 2002;(2):167-74.
    • (2002) Heart Drug , vol.2 , pp. 167-74
    • Raymond, I.1    Pedersen, F.2    Busch-Sorensen, M.3    Green, A.4    Hildebrandt, P.5
  • 14
    • 0345688845 scopus 로고    scopus 로고
    • Prevalence of impaired left ventricular systolic function and heart failure in a middle aged and elderly urban population segment of Copenhagen
    • Raymond I, Pedersen F, Steensgaard-Hansen F, Green A, Busch- Sorensen M, Tuxen C, et al. Prevalence of impaired left ventricular systolic function and heart failure in a middle aged and elderly urban population segment of Copenhagen. Heart. 2003;89(12):1422-9.
    • (2003) Heart. , vol.89 , Issue.12 , pp. 1422-9
    • Raymond, I.1    Pedersen, F.2    Steensgaard-Hansen, F.3    Green, A.4    Busch- Sorensen, M.5    Tuxen, C.6
  • 15
    • 15944419583 scopus 로고    scopus 로고
    • N-terminal pro-brain natriuretic peptide C-reactive protein and urinary albumin levels as predictors of mortality and cardiovascular events in older adults
    • Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA. 2005;293(13): 1609-16.
    • (2005) JAMA. , vol.293 , Issue.13 , pp. 1609-16
    • Kistorp, C.1    Raymond, I.2    Pedersen, F.3    Gustafsson, F.4    Faber, J.5    Hildebrandt, P.6
  • 17
    • 65549134577 scopus 로고    scopus 로고
    • Low grade inflammation as measured by levels of YKL-40: Association with an increased overall and cardiovascular mortality rate in an elderly population
    • Epub ahead of print]
    • Rathcke CN, Raymond I, Kistorp C, Hildebrandt P, Faber J, Vestergaard H. Low grade inflammation as measured by levels of YKL-40: association with an increased overall and cardiovascular mortality rate in an elderly population. Int J Cardiol. 2009 [Epub ahead of print].
    • (2009) Int J Cardiol.
    • Rathcke, C.N.1    Raymond, I.2    Kistorp, C.3    Hildebrandt, P.4    Faber, J.5    Vestergaard, H.6
  • 18
    • 0032993673 scopus 로고    scopus 로고
    • Insulin-like growth factors (IGF-I, free IGF-I and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation
    • Yu H, Mistry J, Nicar MJ, Khosravi MJ, Diamandis A, van DJ, et al. Insulin-like growth factors (IGF-I, free IGF-I and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation. J Clin Lab Anal. 1999;13(4):166-72.
    • (1999) J Clin Lab Anal. , vol.13 , Issue.4 , pp. 166-72
    • Yu, H.1    Mistry, J.2    Nicar, M.J.3    Khosravi, M.J.4    Diamandis, A.5    Van, D.J.6
  • 19
    • 0037469232 scopus 로고    scopus 로고
    • Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association
    • Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107(3):499-511.
    • (2003) Circulation. , vol.107 , Issue.3 , pp. 499-511
    • Pearson, T.A.1    Mensah, G.A.2    Alexander, R.W.3    Anderson, J.L.4    Cannon III, R.O.5    Criqui, M.6
  • 20
    • 0035162742 scopus 로고    scopus 로고
    • Association between insulin-like growth factor status and physical activity levels in rheumatoid arthritis
    • Lemmey A, Maddison P, Breslin A, Cassar P, Hasso N, McCann R, et al. Association between insulin-like growth factor status and physical activity levels in rheumatoid arthritis. J Rheumatol. 2001;28(1):29-34.
    • (2001) J Rheumatol. , vol.28 , Issue.1 , pp. 29-34
    • Lemmey, A.1    Maddison, P.2    Breslin, A.3    Cassar, P.4    Hasso, N.5    McCann, R.6
  • 22
    • 23944499072 scopus 로고    scopus 로고
    • The insulin-like growth factor system and markers of inflammation in adult patients with inflammatory bowel disease
    • Eivindson M, Nielsen JN, Gronbaek H, Flyvbjerg A, Hey H. The insulin-like growth factor system and markers of inflammation in adult patients with inflammatory bowel disease. Horm Res. 2005;64(1):9-15.
    • (2005) Horm Res. , vol.64 , Issue.1 , pp. 9-15
    • Eivindson, M.1    Nielsen, J.N.2    Gronbaek, H.3    Flyvbjerg, A.4    Hey, H.5
  • 23
    • 0029788877 scopus 로고    scopus 로고
    • Local disruption of the insulin-like growth factor system in the arthritic joint
    • Fernihough JK, Billingham ME, Cwyfan-Hughes S, Holly JM. Local disruption of the insulin-like growth factor system in the arthritic joint. Arthritis Rheum. 1996;39(9):1556-65.
    • (1996) Arthritis Rheum. , vol.39 , Issue.9 , pp. 1556-65
    • Fernihough, J.K.1    Billingham, M.E.2    Cwyfan-Hughes, S.3    Holly, J.M.4
  • 24
    • 0035093623 scopus 로고    scopus 로고
    • Changes in systemic levels of insulin-like growth factors and their binding proteins in patients with rheumatoid arthritis
    • Neidel J. Changes in systemic levels of insulin-like growth factors and their binding proteins in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2001;19(1):81-4.
    • (2001) Clin Exp Rheumatol. , vol.19 , Issue.1 , pp. 81-4
    • Neidel, J.1
  • 25
    • 18444366740 scopus 로고    scopus 로고
    • Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant
    • Sesmilo G, Fairfield WP, Katznelson L, Pulaski K, Freda PU, Bonert V, et al. Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant. J Clin Endocrinol Metab. 2002;87(4): 1692-9.
    • (2002) J Clin Endocrinol Metab. , vol.87 , Issue.4 , pp. 1692-9
    • Sesmilo, G.1    Fairfield, W.P.2    Katznelson, L.3    Pulaski, K.4    Freda, P.U.5    Bonert, V.6
  • 26
    • 0035217886 scopus 로고    scopus 로고
    • Inflammatory cardiovascular risk markers in women with hypopituitarism
    • Sesmilo G, Miller KK, Hayden D, Klibanski A. Inflammatory cardiovascular risk markers in women with hypopituitarism. J Clin Endocrinol Metab. 2001;86(12):5774-81.
    • (2001) J Clin Endocrinol Metab. , vol.86 , Issue.12 , pp. 5774-81
    • Sesmilo, G.1    Miller, K.K.2    Hayden, D.3    Klibanski, A.4
  • 27
    • 36248956034 scopus 로고    scopus 로고
    • Concentrations of the acute phase reactants high-sensitive C-reactive protein and YKL-40 and of interleukin-6 before and after treatment in patients with acromegaly and growth hormone deficiency
    • Andreassen M, Vestergaard H, Kristensen LO. Concentrations of the acute phase reactants high-sensitive C-reactive protein and YKL-40 and of interleukin-6 before and after treatment in patients with acromegaly and growth hormone deficiency. Clin Endocrinol (Oxf). 2007;67(6):909-16.
    • (2007) Clin Endocrinol (Oxf). , vol.67 , Issue.6 , pp. 909-16
    • Andreassen, M.1    Vestergaard, H.2    Kristensen, L.O.3
  • 29
    • 0037022910 scopus 로고    scopus 로고
    • Inflammation and atherosclerosis
    • Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105(9):1135-43.
    • (2002) Circulation. , vol.105 , Issue.9 , pp. 1135-43
    • Libby, P.1    Ridker, P.M.2    Maseri, A.3
  • 30
    • 0024996130 scopus 로고
    • Growth hormone and body composition
    • Bengtsson BA, Brummer RJ, Bosaeus I. Growth hormone and body composition. Horm Res. 1990;33(Suppl 4):19-24.
    • (1990) Horm Res. , vol.33 , Issue.SUPPL. 4 , pp. 19-24
    • Bengtsson, B.A.1    Brummer, R.J.2    Bosaeus, I.3
  • 31
    • 68149103024 scopus 로고    scopus 로고
    • The insulin-like growth factor-I receptor as an oncogene
    • Werner H, Bruchim I. The insulin-like growth factor-I receptor as an oncogene. Arch Physiol Biochem. 2009;115(2):58-71.
    • (2009) Arch Physiol Biochem. , vol.115 , Issue.2 , pp. 58-71
    • Werner, H.1    Bruchim, I.2
  • 32
    • 0038173653 scopus 로고    scopus 로고
    • Effects of growth hormone on fluid homeostasis. Clinical and experimental aspects
    • Moller J. Effects of growth hormone on fluid homeostasis. Clinical and experimental aspects. Growth Horm IGF Res. 2003;13(23):55-74.
    • (2003) Growth Horm IGF Res. , vol.13 , Issue.23 , pp. 55-74
    • Moller, J.1
  • 33
    • 65249171425 scopus 로고    scopus 로고
    • Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects
    • Moller N, Jorgensen JO. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev. 2009;30(2):152-77.
    • (2009) Endocr Rev. , vol.30 , Issue.2 , pp. 152-77
    • Moller, N.1    Jorgensen, J.O.2
  • 35
    • 0035667071 scopus 로고    scopus 로고
    • The central role of SOCS-3 in integrating the neuro-immunoendocrine interface
    • Auernhammer CJ, Melmed S. The central role of SOCS-3 in integrating the neuro-immunoendocrine interface. J Clin Invest. 2001;108(12):1735-40.
    • (2001) J Clin Invest. , vol.108 , Issue.12 , pp. 1735-40
    • Auernhammer, C.J.1    Melmed, S.2
  • 36
    • 0034806471 scopus 로고    scopus 로고
    • YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes
    • De CF, Gaufillier S, Bonnaud A, Sabatini M, Lesur C, Pastoureau P. YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes. Biochem Biophys Res Commun. 2001;285(4):926-31.
    • (2001) Biochem Biophys Res Commun. , vol.285 , Issue.4 , pp. 926-31
    • De, C.F.1    Gaufillier, S.2    Bonnaud, A.3    Sabatini, M.4    Lesur, C.5    Pastoureau, P.6
  • 37
    • 0036645699 scopus 로고    scopus 로고
    • The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways
    • Recklies AD, White C, Ling H. The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways. Biochem J. 2002;365(Pt 1):119-26.
    • (2002) Biochem J. , vol.365 , Issue.PART 1 , pp. 119-26
    • Recklies, A.D.1    White, C.2    Ling, H.3
  • 38
    • 0032937597 scopus 로고    scopus 로고
    • A new family of growth factors produced by the fat body and active on Drosophila imaginal disc cells
    • Kawamura K, Shibata T, Saget O, Peel D, Bryant PJ. A new family of growth factors produced by the fat body and active on Drosophila imaginal disc cells. Development. 1999; 126(2):211-9.
    • (1999) Development. , vol.126 , Issue.2 , pp. 211-9
    • Kawamura, K.1    Shibata, T.2    Saget, O.3    Peel, D.4    Bryant, P.J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.